Cancer Plus

About the Journal

Co-Editors-in-Chief: Prof. Jun Chen, Dr. Chong Li

ISSN: 2661-3840 (Online) 

          2661-3832 (Print) 

Publishing Frequency: Quarterly (four issues per year)

Article Processing Charges (APC): Click here for more details

Publishing Model: Open Access

Collaborating Institution: Medical Immunodiagnosis Research Center, Institute of Biophysics, Chinese Academy of Sciences

  

Cancer Plus is a new research journal dedicated to the publication of findings in cancer research. This journal is a joint collaboration between Whioce Publishing Pte. Ltd. (Singapore) and the Chinese Academy of Sciences (China).

We encourage researchers to publish the latest findings in cancer research, including preliminary results, repeated argumentation studies and negative results. The journal welcomes various types of submissions, e.g. research papers, clinical research reports, review articles.

Cancer Plus is indexed by CNKI and Google Scholar. Currently, Cancer Plus is working towards being indexed by BIOSIS, Scopus, PubMed and Science Citation Index Expanded (SCIE).


Recent Articles

Research Article

Zhihong Zhang, Yazhi Xiao, Xinrong He, Yiyao Chen, Hailong Sheng, Zhenru Zhu, Jingyuan Sun, Chuanhui Cao
64 Views, 16 PDF Downloads, 6 Suppl. File Downloads

Case Report

Shwetal Sonvane, Naveen Kumar Gupta, Jyoutishman Saikia, Ruchi Rathore, Sagir Akhtar, Mukurdipi Ray
148 Views, 49 PDF Downloads

Research Article

Yanwei Zhao, Zhenxing Wang, Xizi Wang, Xiaodong Jia, Mingjun Li
247 Views, 126 PDF Downloads

Research Article

Hülya Çiçek, Hanım Seval Savaş, Mustafa Yıldırım, Hüseyin Gürbüz
142 Views, 56 PDF Downloads

Case Report

Wafa Ibrahim Khatri, Hitesh Rajendra Singhavi, Tahoora Sarguroh, Merene Meenu, Kantamani Bala Teja, Boman Dabur, Anil Heroor
196 Views, 89 PDF Downloads

Research Article

María Inés Johnson Castro, Paulina Hurtado Arenas
337 Views, 124 PDF Downloads

Announcements

 

Congratulations!

 
 
Posted: 2023-01-31
 

A Study on the Impact of the COVID-19 Pandemic on Pediatric Oncology Providers Globally

 

Coronavirus disease 2019 (COVID-19) disrupted pediatric oncology care globally, increasing demands on health care providers (HCPs) who adapted to continue care. Elizabeth R. Sniderman, et al. sought to characterize the pandemic's impact on pediatric oncology HCPs worldwide. Result shows that COVID-19 had a profound impact on the pediatric oncology workforce, creating challenging modifications to staffing and resulting in physical, psychological, and financial distress. Despite these challenges, HCPs caring for children with cancer came together to continue to provide high-quality care. More details, please click here.

Figure 1. Survey respondents and focus-group institutions. Countries represented by survey respondents (green, categorized by country income classification) and focus groups. Responses were received from 79 countries; focus groups were held in 16 countries.

 
Posted: 2022-02-10 More...
 

Updated Lung Cancer Screening Guidelines

 

When it comes to lung cancer, the statistics are grim. Only 15 percent of patients are still alive five years after diagnosis because symptoms often don’t appear until later stages, and about 70 percent of people have advanced disease at the time they’re diagnosed, according to a study published in February 2020 in The New England Journal of Medicine (NEJM).

Figure 1The new, broader, lung cancer screening guidelines make it easier for women and Black Americans to be eligible for lung cancer screening. @ Getty Images

 
Posted: 2021-09-23 More...
 
More Announcements...